Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
US-9845346-B2 · Dec 19, 2017 · US
Biomarin Pharmaceurical Inc was listed as an assignee on 1 patent publication in 2017.
| Metric | Value |
|---|---|
| Company | Biomarin Pharmaceurical Inc |
| Year | 2017 |
| Patents | 1 |
Representative publications for Biomarin Pharmaceurical Inc in 2017.
Most common classification codes for Biomarin Pharmaceurical Inc in 2017.
Navigate to parent entity pages.